Open Market Consultation - Drugs Detect Consortium
The Drugs Detect Consortium has recently started a market consultation in preparation for an acquisition/procurement of innovative solutions for the automatic detection of a wide range of drugs in correctional institutions and prisons for a total budget of 3 880 000.00 EUR (for example, devices that detect traces of drugs or suspicious objects that contain drugs, solutions for automatic detection of suspicious behaviour that indicates possession of drugs etc.).
Companies that offer relevant solutions are invited to participate in 1 physical meeting on the 7th of July 2022 in Brussels, Belgium and 4 days of virtual one-on-one meetings between the 12th and 15th of July 2022. During these meetings, the Drugs Detect Consortium will explain its needs, outline the procurement process, and inquire into companies' capabilities to deliver innovative drug detection solutions. Suppliers will also have the opportunity to exchange information and find partners. Upon registration, market parties will be provided additional information on the needs and requested to answer a list of questions. For more information on the open market consultation, see https://drug-detect.eu/open-market-consultation/. For information about registration, the agenda, and the possibility of coming in contact with other relevant organisations, please follow: https://ddc2022.b2match.io/home
The project is co-funded by the COSME's programme of the European Union and kicked off in January 2022 with 36 months duration. Drugs Detect Consortium is addressing a need that is widely shared by prisons throughout Europe. In this context, the project has gathered a representative, geographically balanced consortium of 4 public prison service agencies (KEMEA, DJI, DG-EPI, ESMIR) from 4 European countries (Greece, Netherlands, Belgium, Spain) with together an average inmates population of 40.000.